A 28-year-old woman with intermittent wheeze and cough is diagnosed with mild asthma. She has daytime symptoms twice per week, nocturnal symptoms twice per month, and normal lung function when asymptomatic. According to the 2021 Canadian Thoracic Society asthma guideline, which initial pharmacologic regimen is preferred to reduce exacerbation risk?